Analytical technology development to monitor the stability of Polysaccharide-Protein conjugate vaccines.

Saved in:
Bibliographic Details
Title: Analytical technology development to monitor the stability of Polysaccharide-Protein conjugate vaccines.
Authors: Smith WJ; Vaccine Drug Product Development, Pharmaceutical Sciences and Clinical Supplies, Merck & Co., Inc., West Point, PA, 19486, USA. Electronic address: william_smith2@merck.com., Ahl PL; Vaccine Drug Product Development, Pharmaceutical Sciences and Clinical Supplies, Merck & Co., Inc., West Point, PA, 19486, USA., Wang B; Vaccine Drug Product Development, Pharmaceutical Sciences and Clinical Supplies, Merck & Co., Inc., West Point, PA, 19486, USA., Hamm M; Vaccine Analytical Research and Development, MRL, Merck & Co., Inc., West Point, PA, 19486, USA., Rustandi RR; Vaccine Analytical Research and Development, MRL, Merck & Co., Inc., West Point, PA, 19486, USA., Winters MA; Vaccine Process Research and Development, MRL, Merck & Co., Inc., West Point, PA, 19486, USA., Blue JT; Vaccine Drug Product Development, Pharmaceutical Sciences and Clinical Supplies, Merck & Co., Inc., West Point, PA, 19486, USA.
Source: Vaccine [Vaccine] 2022 Jul 29; Vol. 40 (31), pp. 4182-4189. Date of Electronic Publication: 2022 Jun 07.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2518
DOI:10.1016/j.vaccine.2022.05.056